ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 2343

$1.3M Total Retail Price of All Prescriptions

Rank: 41 out of 2343

563 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 22,465 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 1,087 967 1 5
WARFARIN SODIUM 1,055 840 2 8
PRAVASTATIN SODIUM 959 763 3 15
METOPROLOL TARTRATE 900 820 4 7
FUROSEMIDE 813 679 5 6
LISINOPRIL 812 690 6 3
OMEPRAZOLE 704 560 7 4
HYDROCODONE-ACETAMINOPHEN 683 482 S3 8 13
LEVOTHYROXINE SODIUM 659 525 9 2
METFORMIN HCL 453 304 10 9
PREDNISONE 434 332 11 37
SIMVASTATIN 427 314 12 1
POTASSIUM CHLORIDE 406 323 13 18
RANITIDINE HCL 399 285 14 43
GLIPIZIDE 395 320 15 56
GABAPENTIN 395 278 15 16
METOPROLOL SUCCINATE 306 279 17 14
FLUTICASONE PROPIONATE 306 212 17 46
ATORVASTATIN CALCIUM 302 267 19 10
AZITHROMYCIN 291 201 20 39
CITALOPRAM HBR 281 249 21 17
MIRTAZAPINE 280 259 22 41
ATENOLOL 249 234 23 12
ENALAPRIL MALEATE 247 195 24 58
DIOVAN 241 185 25 23
ALENDRONATE SODIUM 232 204 26 28
DONEPEZIL HCL 231 231 27 21
GLIPIZIDE XL 221 192 28 84
FLUOXETINE HCL 218 167 29 82
KLOR-CON M10 196 130 30 107
TRICOR 195 142 31 96
KLOR-CON M20 187 164 32 44
ESCITALOPRAM OXALATE 183 174 33 55
POLYETHYLENE GLYCOL 3350 175 147 34 54
METOLAZONE 160 128 35 173
NAMENDA 160 160 35 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 156 116 37 120
CYMBALTA 155 109 38 74
HYDROCHLOROTHIAZIDE 155 146 38 11
GLIPIZIDE ER 151 144 40 115
ADVAIR DISKUS 150 86 41 34
DIGOXIN 150 150 41 35
NEXIUM 148 122 43 33
SERTRALINE HCL 147 109 44 20
EXELON 146 140 45 129
PANTOPRAZOLE SODIUM 145 110 46 22
CLOPIDOGREL 140 133 47 26
CARBIDOPA-LEVODOPA 139 139 48 85
ISOSORBIDE MONONITRATE ER 139 139 48 32
ALLOPURINOL 133 118 50 31
TOPIRAMATE 130 56 51 220
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 118 51 42
ABILIFY 128 105 53 159
CLONIDINE HCL 125 114 54 70
DICLOFENAC SODIUM 122 47 55 155
PLAVIX 120 111 56 38
EVISTA 119 106 57 128
DIVALPROEX SODIUM 117 89 58 105
PAROXETINE HCL 117 108 58 66
LOSARTAN POTASSIUM 115 97 60 19
NOVOLOG 114 100 61 110
LOVAZA 106 95 62 113
IRBESARTAN 103 88 63 270
METHYLPREDNISOLONE 103 76 63 122
QUINAPRIL HCL 100 81 65 73
BENAZEPRIL HCL 100 60 65 113
LEVETIRACETAM 98 74 67 104
CRESTOR 97 66 68 30
TRAMADOL HCL 95 87 69 25
RISPERIDONE 93 87 70 61
TAMSULOSIN HCL 92 92 71 29
LYRICA 92 75 71 135
FENTANYL 91 57 S2 73 69
CYCLOBENZAPRINE HCL 91 15 R 73 109
IPRATROPIUM-ALBUTEROL 89 75 75 99
ALBUTEROL SULFATE 89 82 75 126
NYSTATIN 89 47 75 172
RIVASTIGMINE 86 86 78 395
SPIRONOLACTONE 84 57 79 65
OXYBUTYNIN CHLORIDE 83 61 80 169
GLIMEPIRIDE 81 54 81 45
LANTUS 77 53 82 51
NIASPAN 76 54 83 141
RAMIPRIL 76 62 83 90
SPIRIVA 76 51 83 48
OXYBUTYNIN CHLORIDE ER 72 60 86 149
LOVASTATIN 71 50 87 47
METFORMIN HCL ER 71 58 87 88
ONGLYZA 71 32 87 211
AMLODIPINE BESYLATE-BENAZEPRIL 71 58 87 59
MECLIZINE HCL 70 63 91 103
CARVEDILOL 69 68 92 27
TRIAMCINOLONE ACETONIDE 69 38 92 137
OLANZAPINE 68 68 94 121
ROPINIROLE HCL 67 52 95 124
LEVOFLOXACIN 67 56 95 106
DIOVAN HCT 67 58 95 63
SINGULAIR 67 67 95 100
ZOLPIDEM TARTRATE 67 60 95 24
LEXAPRO 66 59 100 178
ACTONEL 66 56 100 182
FENOFIBRATE 65 48 102 94
VERAPAMIL ER 64 61 103 95
CEPHALEXIN 64 55 103 111
FAMOTIDINE 62 39 105 60
CHLORTHALIDONE 62 62 105 183
GLYBURIDE 61 60 R 107 62
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 107 64
VENTOLIN HFA 61 28 107 79
NOVOLOG MIX 70-30 FLEXPEN 61 38 107 335
TORSEMIDE 59 59 111 157
INSULIN SYRINGE 58 34 112 102
TRILIPIX 58 48 112 214
OXYCODONE-ACETAMINOPHEN 56 21 S2 114 49
ASTEPRO 56 32 114 553
NITROFURANTOIN MONO-MACRO 56 55 114 244
LACTULOSE 55 49 117 139
IBUPROFEN 55 31 117 75
AMOX TR-POTASSIUM CLAVULANATE 53 27 119 160
AGGRENOX 53 44 119 174
BUDESONIDE 53 51 119 313
CIPROFLOXACIN HCL 53 50 119 72
VENLAFAXINE HCL ER 52 47 123 87
DEXILANT 51 25 124 184
MORPHINE SULFATE ER 51 29 S2 124 142
SUCRALFATE 51 35 124 248
LIPITOR 51 37 124 78
SYNTHROID 50 50 128 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.